Johanna Rimpiläinen

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia

Kimmo Porkka, Perttu Koskenvesa, Tuija Lundán et al. · Blood · 2008 · 437 citations · Full text

<i>Ex vivo</i> venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia

Heikki Kuusanmäki, Sari Kytölä, Ida Vänttinen et al. · Haematologica · 2022 · 46 citations · Full text

Engraftment and outcome after autologous stem cell transplantation in plerixafor‐mobilized non‐<scp>H</scp>odgkin's lymphoma patients

Ville Varmavuo, Johanna Rimpiläinen, Hanne Kuitunen et al. · Transfusion · 2013 · 30 citations

Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial

Sari Kytölä, Ida Vänttinen, Tanja Ruokoranta et al. · Blood · 2024 · 24 citations

Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group

Riikka Räty, Tuomo Honkanen, Esa Jantunen et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 18 citations

Hematological Malignancy, Lymphoid Neoplasia, Severe Infections +14